Skip to main content
Caplight Logo









Bloom Science

Bloom Science

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://bloomscience.com/

Last Round

Series A

Dec 9, 2021

Total Funding Raised

$12.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bloom Science is a biotechnology company that develops live biotherapeutic products and genetically optimized living medicines for severe metabolic and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

live biotherapeutic productsLBPgut-brain axisdrug discovery platformmicrobiome therapeuticsketogenic dietsynthetic biologymultiomicsmetabolic disordersneurological disordersbiotechmicrobiome drugsclinical stageai drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bloom Science Comparables

Compare Bloom Science with similar companies based on industry and business-model similarity.

Bloom Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
YSOPIA Bioscience
78%
Genome & Company
78%
New Biotic, Inc.
77%

Bloom Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 9, 2021
GrantMar 17, 2020
GrantSep 3, 2019
SeedMay 24, 2018

Key People

Founding team and executive leadership

Christopher Reyes

CEO, Co-Founder, Director

Founding Team

Bloom Science Investors

Notable investors and investment history

Bloom Science investors
InvestorRounds
The ALS AssociationGrant
Epilepsy FoundationGrant
ALS Investment FundSeries A
Joyance PartnersSeed, Series A
Leaps by BayerSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 33% MoM, reaching 2.2K.

  • Jan 8, 2026

    Leadership team to speak at Sachs Neuroscience Innovation Forum.

Bloom Science Filings

Explore SEC and related filing metadata, where available.

Bloom Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bloom Science's valuation, stock price, and market status.

Is Bloom Science a public or private company?

Bloom Science is a private company.

What is the current stock price of Bloom Science?

Bloom Science is a private company with no public stock price. No recent secondary market data is available.

How much is Bloom Science worth (valuation)?

Valuation information for Bloom Science is not publicly available.

Can I buy Bloom Science stock?

Bloom Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bloom Science's last funding round?

Bloom Science's most recent funding round was Series A on December 9, 2021.

Who are the main investors in Bloom Science?

Key investors in Bloom Science include ALS Investment Fund, Leaps by Bayer.

Will Bloom Science IPO soon?

No public IPO plans have been announced for Bloom Science.

How can I track Bloom Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bloom Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range15
Year Founded2018
Last FundingDec 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?